SCHEMBL312241

SCHEMBL312241

CCOC(=O)Nc1cc(O)ccc1-c1cc(=O)c2ccc(O)cc2[nH]1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
HSD17B10 Q99714 2/20 0.43
ALOX15 P16050 1/20 0.43
CYP1A2 P05177 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.40
AKR1B1 P15121 1/20 0.40
HPGD P15428 3/20 0.39
KDM4E B2RXH2 2/20 0.39
GAA P10253 2/20 0.39
GLA P06280 1/20 0.39
LMNA P02545 1/20 0.39
TUBB4A P04350 1/20 0.39
TUBB P07437 1/20 0.39
TUBA3C P0DPH7 1/20 0.39
TUBA1B P68363 1/20 0.39
TUBA4A P68366 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL311994 0.93 KMT2A (0.46) ALDH1A1MEN1KMT2AHSD17B10ALOX15
SCHEMBL10215441 0.91 KDM4E (0.45) ALDH1A1MEN1KMT2AHSD17B10SMN1; SMN2
SCHEMBL311700 0.91 ALDH1A1 (0.41) ALDH1A1MEN1KMT2AHSD17B10ALOX15
SCHEMBL312303 0.91 TUBB4A (0.40) ALDH1A1MEN1KMT2AHSD17B10ALOX15
SCHEMBL311883 0.91 GAA (0.46) ALDH1A1MEN1KMT2AHSD17B10CYP1A2
SCHEMBL311421 0.89 MEN1 (0.42) ALDH1A1MEN1KMT2AHSD17B10ALOX15
SCHEMBL312803 0.87 ALDH1A1 (0.41) ALDH1A1MEN1KMT2AHSD17B10ALOX15
SCHEMBL312016 0.86 HPGD (0.51) ALDH1A1MEN1KMT2AHSD17B10SMN1; SMN2
SCHEMBL312382 0.86 CYP1A2 (0.39) ALDH1A1MEN1KMT2AHSD17B10ALOX15
SCHEMBL312167 0.85 CYP1A2 (0.38) ALDH1A1MEN1KMT2AHSD17B10ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8093273-B2 Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases RESVERLOGIX CORP. (CA) 2012-01-10 US disclosed
EP-2332527-A2 Flavanoids and Isoflavanoids for the prevention and treatment of cardiovascular diseases RESVERLOGIX CORP. (CA) 2011-06-15 EP disclosed